MANILA, Philippines — Two developers of vaccines against COVID-19 may soon get their initial clearance from the vaccine expert panel (VEP) of the Department of Science and Technology (DOST), which they need to conduct phase 3 clinical trials here in the Philippines.
Dr. Nina Gloriani, head of the DOST’s VEP, said Friday that the panel has deferred action on the application of Belgium-based Janssen Pharmaceutical, which had only submitted on Wednesday their updated responses to comments of the body.
“We still have to meet again to discuss our final action. If we are satisfied with their responses, we may actually grant technical clearance so that SJREB (Single Joint Research Ethic…
Keep on reading: Janssen, AstraZeneca may soon get initial clearance for phase 3 trials in PH